Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

Parabolic Drugs Ltd (PARB)

NSE
Currency in INR
Disclaimer
5.50
0.00(0.00%)
Closed
PARB Scorecard
Trading near 52-week High
Fair Value
Unlock Value
Day's Range
5.505.50
52 wk Range
5.505.50
Prev. Close
5.75
Open
5.5
Day's Range
5.5-5.5
52 wk Range
5.5-5.5
Volume
0
Average Volume (3m)
43,205
1-Year Change
0%
Shares Outstanding
61,892,014
Fair Value
Unlock
Dividends Payment Streak
Unlock
Technical
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Daily
Weekly
Monthly
More
How do you feel today about PARB?
Vote to see community's results!
or

Parabolic Drugs Ltd Company Profile

Parabolic Drugs Limited develops, manufactures, and sells active pharmaceutical ingredients (API) and API intermediates in India. The company offers oral and sterile semi synthetic penicillin APIs; oral and sterile cephalosporin APIs in antibiotic area; non-antibiotic APIs for cardiovascular, NSAID, anti-hypertensive, and osteoporosis therapeutic areas; and calcium sennoside, colchicine, raubasine, reserpine, thiocolchicoside, vinpocetine, and yohimbine. It also provides custom research and manufacturing services to pharma companies, including research and development, and manufacturing services for NCE and generics; IPR support for process design and infringement guidance; and QA, QC, and regulatory support for meeting quality and documentation requirements. The company also exports its products to approximately 51 countries. Parabolic Drugs Limited was founded in 1996 and is based in Chandigarh, India.

Employees
1000
Market
India
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.